SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Prelude Therapeutics Incorporated (NASDAQ: PRLD) and Encourages Investors to Contact the Firm

<p>PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Prelude Therapeutics Incorporated (NASDAQ: PRLD) (“Prelude”) on behalf of the company’s investors. Since April 2023, shares of Prelude’s common stock have declined in value from a trading price of over $6.00 per share to a current trading price of approximately […]</p>
<p>The post <a href="https://forextv.com/top-news/shareholder-alert-kaskela-law-llc-announces-investigation-of-prelude-therapeutics-incorporated-nasdaq-prld-and-encourages-investors-to-contact-the-firm/">SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Prelude Therapeutics Incorporated (NASDAQ: PRLD) and Encourages Investors to Contact the Firm</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>